Business Description
Cannabix Technologies Inc
NAICS : 334512
SIC : 3911
ISIN : CA13765L1013
Description
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 24.69 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 118.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -10.4 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | 5.6 | |||||
3-Year Book Growth Rate | -33.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.76 | |||||
9-Day RSI | 61.07 | |||||
14-Day RSI | 52.67 | |||||
3-1 Month Momentum % | -13.95 | |||||
6-1 Month Momentum % | 9.47 | |||||
12-1 Month Momentum % | 3.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.45 | |||||
Quick Ratio | 5.99 | |||||
Cash Ratio | 4.92 | |||||
Days Inventory | 179.73 | |||||
Days Sales Outstanding | 136.76 | |||||
Days Payable | 651.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.46 | |||||
Operating Margin % | -3970.25 | |||||
Net Margin % | -3963.92 | |||||
EBITDA Margin % | -3847.47 | |||||
FCF Margin % | -1192.86 | |||||
OCF Margin % | -1192.86 | |||||
ROE % | -276.85 | |||||
ROA % | -244.8 | |||||
ROIC % | -1713 | |||||
3-Year ROIIC % | -638.03 | |||||
ROC (Joel Greenblatt) % | -1890.74 | |||||
ROCE % | -275.81 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 602.26 | |||||
PB Ratio | 46.33 | |||||
Price-to-Tangible-Book | 36 | |||||
EV-to-EBIT | -11.42 | |||||
EV-to-EBITDA | -11.72 | |||||
EV-to-Revenue | 451.09 | |||||
EV-to-FCF | -36.8 | |||||
| Price-to-Net-Current-Asset-Value | 36 | |||||
| Price-to-Net-Cash | 36 | |||||
Earnings Yield (Greenblatt) % | -8.76 | |||||
FCF Yield % | -2.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cannabix Technologies Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.098 | ||
| EPS (TTM) (€) | -0.033 | ||
| Beta | -0.5535 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 1.6 | ||
| Volatility % | 45.49 | ||
| 14-Day RSI | 52.67 | ||
| 14-Day ATR (€) | 0.012253 | ||
| 20-Day SMA (€) | 0.3393 | ||
| 12-1 Month Momentum % | 3.35 | ||
| 52-Week Range (€) | 0.292 - 0.55 | ||
| Shares Outstanding (Mil) | 122.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cannabix Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cannabix Technologies Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cannabix Technologies Inc Frequently Asked Questions
What is Cannabix Technologies Inc(FRA:8CT)'s stock price today?
The current price of FRA:8CT is €0.36. The 52 week high of FRA:8CT is €0.55 and 52 week low is €0.29.
When is next earnings date of Cannabix Technologies Inc(FRA:8CT)?
The next earnings date of Cannabix Technologies Inc(FRA:8CT) is .
Does Cannabix Technologies Inc(FRA:8CT) pay dividends? If so, how much?
Cannabix Technologies Inc(FRA:8CT) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection | 2026-07-08 |
Articles on Cannabix Technologies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers